Suppr超能文献

术后需重症监护并发腹膜炎患者中多重耐药菌的危险因素。

Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.

机构信息

Service de Réanimation Chirurgicale, Université Rennes 1, INSERM U991, Hôpital de Pontchaillou, 2 rue Henri Le Guilloux, 35033 Rennes Cedex 9, Rennes, France.

出版信息

J Antimicrob Chemother. 2010 Feb;65(2):342-6. doi: 10.1093/jac/dkp439. Epub 2009 Dec 11.

Abstract

OBJECTIVES

This prospective non-interventional study investigated the risk factors for multidrug-resistant bacteria (MDRB) in patients with post-operative peritonitis (POP), to provide guidance for empirical antimicrobial therapy.

METHODS

All consecutive patients, >15 years old, admitted to a surgical intensive care unit (ICU) between September 2006 and January 2009 for a first episode of POP were included. Antibiotic susceptibilities of microorganisms recovered from blood cultures and peritoneal fluid were determined by disc diffusion. Amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, gentamicin, amikacin and ciprofloxacin were tested against Gram-negative bacteria, and oxacillin, amoxicillin, vancomycin, gentamicin and erythromycin were tested against aerobic Gram-positive bacteria. Results were reported as susceptible or resistant.

RESULTS

MDRB were isolated from 20/115 (17%) patients. In univariate analysis, use of antimicrobial therapy during the 3 months prior to hospitalization and a long duration between hospital admission or first operation and relaparotomy were significantly associated with MDRB recovery. In multivariate analysis, only antimicrobial treatment in the 3 months preceding hospitalization and duration between first operation and relaparotomy were independent risk factors for MDRB [odds ratio (OR) = 5.80, 95% confidence interval (95% CI) = 1.99-16.91 and OR = 1.10, 95% CI = 1.02-1.19, respectively]. No MDRB were found when the delay between the first operation and relaparotomy was <5 days. POP severity, non-surgical and surgical complications, hospital and ICU length of stay, and mortality were similar in patients with and without MDRB.

CONCLUSIONS

Our results suggest that broad-spectrum antibiotics should be used in ICU patients with POP who have received antimicrobial therapy in the 3 months prior to hospitalization, or with >5 days between the first operation and relaparotomy.

摘要

目的

本前瞻性非干预性研究旨在探讨术后腹膜炎(POP)患者中多重耐药菌(MDRB)的危险因素,为经验性抗菌治疗提供指导。

方法

纳入 2006 年 9 月至 2009 年 1 月期间因首次发生 POP 而入住外科重症监护病房(ICU)的所有年龄>15 岁的连续患者。采用纸片扩散法测定从血培养和腹腔液中分离的微生物的抗生素敏感性。对革兰氏阴性菌进行阿莫西林/克拉维酸、替卡西林/克拉维酸、哌拉西林/他唑巴坦、头孢噻肟、头孢他啶、头孢吡肟、亚胺培南、庆大霉素、阿米卡星和环丙沙星的检测,对需氧革兰氏阳性菌进行苯唑西林、阿莫西林、万古霉素、庆大霉素和红霉素的检测。结果报告为敏感或耐药。

结果

115 例患者中有 20 例(17%)分离出 MDRB。单因素分析显示,住院前 3 个月使用抗菌药物治疗以及住院或首次手术与再次剖腹手术之间的时间较长与 MDRB 恢复显著相关。多因素分析显示,仅住院前 3 个月的抗菌治疗和首次手术与再次剖腹手术之间的时间是 MDRB 的独立危险因素[比值比(OR)=5.80,95%置信区间(95%CI)=1.99-16.91 和 OR=1.10,95%CI=1.02-1.19]。当首次手术与再次剖腹手术之间的时间<5 天时,未发现 MDRB。MDRB 患者与无 MDRB 患者的 POP 严重程度、非手术和手术并发症、住院和 ICU 住院时间以及死亡率相似。

结论

我们的结果表明,对于 ICU 中患有 POP 且在住院前 3 个月内接受过抗菌治疗或首次手术与再次剖腹手术之间时间>5 天的患者,应使用广谱抗生素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验